NCT04423289

Telematic Monitoring Through a Mobile Application of Patients With COVID-19

Completed NA Last updated 9 June 2020

What this trial tests

NA trial testing Farmalarm in Face-to-face Reconsultation to Emergency Room in 150 participants. Completed in 18 May 2020.

Timeline

31 March 2020

Primary endpoint
4 May 2020

18 May 2020

Quick facts

Lead sponsor	Hospital Universitari Vall d'Hebron Research Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	150
Start date	31 March 2020
Primary completion	4 May 2020
Estimated completion	18 May 2020
Sites	1 location across Spain

Drugs / interventions tested

• Farmalarm

Conditions studied

• Face-to-face Reconsultation to Emergency Room — all drugs for Face-to-face Reconsultation to Emergency Room →

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Who can join

18 and older, any sex, with Face-to-face Reconsultation to Emergency Room. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Open-label randomized clinical trial, one center, to compare the need for face-to-face re-consultation after discharge for COVID-19 between a telematic monitoring through a mobile app and the regular primary care setting.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial.
   Marquez-Algaba E, Sanchez M, Baladas M, España C, et al · · 2022 · cited 3× · PMID 35055339 · DOI 10.3390/jpm12010024